Biocon Biologics
Ioannis Kantelis is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Country Manager at Biocon Biologics since December 2023. Prior to this role, Ioannis held the position of Commercial Director at Viatris from November 2020 to December 2023 and served in various leadership roles at Mylan between March 2015 and November 2020, including Commercial Director and Marketing Director. Earlier career experiences include key positions at Abbott Hellas from December 1994 to February 2015, where responsibilities spanned Market Access & Business Development Director, Business Unit Manager, and Regional Sales Manager, among others. Ioannis holds a Master's degree in Chemical Engineering and a Bachelor's degree in the same field, both from the National Technical University of Athens.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics